Assessing long-term and rare adverse effects of medicines

Keyphrases

• 5α-reductase Inhibitors 33%
• Adverse Effects 100%
• Age Matching 33%
• Benefit-risk Assessment 33%
• Cancer Risk 33%
• Cancer-related 33%
• Causal Research 33%
• Duration of Use 33%
• Inexact Matching 33%
• Long-term Adverse Effects 33%
• Low-dose Aspirin 33%
• Male Breast Cancer 33%
• Methodological Study 33%
• Neovascular Age-related Macular Degeneration (nAMD) 33%
• New Evidence 33%
• New Medicines 100%
• Number of Patients 33%
• Pharmaceutical Companies 33%
• Pharmacovigilance 33%
• Potential Risk 66%
• Preapproval 66%
• Regulatory Agencies 33%
• Risk Management Strategies 33%
• Safety Concerns 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylsalicylic Acid 50%
• Adverse Drug Reaction 50%
• Case-Control Study 100%
• Clinical Study 50%
• Male Breast Cancer 50%
• Malignant Neoplasm 100%
• Observational Study 50%
• Pharmacovigilance 50%
• Steroid 5alpha Reductase Inhibitor 50%
• Wet Macular Degeneration 50%